Hall Ashley 4
4 · Reneo Pharmaceuticals, Inc. · Filed Nov 15, 2021
Insider Transaction Report
Form 4
Hall Ashley
Chief Development Officer
Transactions
- Award
Common Stock
2021-11-12+30,000→ 30,000 total - Award
Stock Option (right to buy)
2021-11-12+180,000→ 180,000 totalExercise: $8.85Exp: 2031-11-11→ Common Stock (180,000 underlying)
Footnotes (2)
- [F1]Represents a restricted stock unit award.
- [F2]1/4 of the shares subject to the stock option vest and become exercisable on October 11, 2022, and the remaining shares vest in equal monthly installments over the subsequent 36 months.